Cargando…
PW02-041 - Canakinumab treatment regimens in CAPS-patients
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952126/ http://dx.doi.org/10.1186/1546-0096-11-S1-A182 |
_version_ | 1782307169733967872 |
---|---|
author | Hofer, F Endres, T Kortus-Götze, B Blank, N Weißbarth-Riedel, E Schuetz, C Kallinich, T Krause, K Rietschel, C Horneff, G Kuemmerle-Deschner, J |
author_facet | Hofer, F Endres, T Kortus-Götze, B Blank, N Weißbarth-Riedel, E Schuetz, C Kallinich, T Krause, K Rietschel, C Horneff, G Kuemmerle-Deschner, J |
author_sort | Hofer, F |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3952126 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39521262014-03-24 PW02-041 - Canakinumab treatment regimens in CAPS-patients Hofer, F Endres, T Kortus-Götze, B Blank, N Weißbarth-Riedel, E Schuetz, C Kallinich, T Krause, K Rietschel, C Horneff, G Kuemmerle-Deschner, J Pediatr Rheumatol Online J Meeting Abstract BioMed Central 2013-11-08 /pmc/articles/PMC3952126/ http://dx.doi.org/10.1186/1546-0096-11-S1-A182 Text en Copyright © 2013 Hofer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Meeting Abstract Hofer, F Endres, T Kortus-Götze, B Blank, N Weißbarth-Riedel, E Schuetz, C Kallinich, T Krause, K Rietschel, C Horneff, G Kuemmerle-Deschner, J PW02-041 - Canakinumab treatment regimens in CAPS-patients |
title | PW02-041 - Canakinumab treatment regimens in CAPS-patients |
title_full | PW02-041 - Canakinumab treatment regimens in CAPS-patients |
title_fullStr | PW02-041 - Canakinumab treatment regimens in CAPS-patients |
title_full_unstemmed | PW02-041 - Canakinumab treatment regimens in CAPS-patients |
title_short | PW02-041 - Canakinumab treatment regimens in CAPS-patients |
title_sort | pw02-041 - canakinumab treatment regimens in caps-patients |
topic | Meeting Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952126/ http://dx.doi.org/10.1186/1546-0096-11-S1-A182 |
work_keys_str_mv | AT hoferf pw02041canakinumabtreatmentregimensincapspatients AT endrest pw02041canakinumabtreatmentregimensincapspatients AT kortusgotzeb pw02041canakinumabtreatmentregimensincapspatients AT blankn pw02041canakinumabtreatmentregimensincapspatients AT weißbarthriedele pw02041canakinumabtreatmentregimensincapspatients AT schuetzc pw02041canakinumabtreatmentregimensincapspatients AT kallinicht pw02041canakinumabtreatmentregimensincapspatients AT krausek pw02041canakinumabtreatmentregimensincapspatients AT rietschelc pw02041canakinumabtreatmentregimensincapspatients AT horneffg pw02041canakinumabtreatmentregimensincapspatients AT kuemmerledeschnerj pw02041canakinumabtreatmentregimensincapspatients |